Effects of Velzatinib in people with kidney problems
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how a medicine called velzatinib affects people with moderate or severe kidney problems compared to those with normal kidney function. The goal is to see if the medicine is safe and how it is processed by the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have moderate or severe kidney problems, or you have normal kidney function.
- Your blood pressure and heart rate are within certain limits.
- You do not have significant heart, liver, or other medical conditions.
- You are not on dialysis and have not had a kidney transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes the drug velzatinib in people with different levels of liver function, compared to those with healthy livers. The results may help doctors determine the right dose for people with liver problems.
This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.
This study tests the drug cabozantinib in people with kidney cancer who are also on dialysis. It aims to see if the drug is safe and works for this group.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests an experimental drug called INCB161734 in people with severe kidney disease or those on dialysis. It aims to see how the drug behaves in the body and if it is safe.
This trial tests a new medicine (nemtabrutinib) in people with severe kidney disease to see how the body handles it. The study helps doctors decide safe doses for people with kidney problems.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.